EDESA BIOTECH, INC. Related Party Transaction, Expenses from Transactions with Related Party
EDESA BIOTECH, INC. (EDSA) reported Related Party Transaction, Expenses from Transactions with Related Party of $20.00 thousand for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-11.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty · last filed 2023-05-11
- EDESA BIOTECH, INC. related party transaction, expenses from transactions with related party for the quarter ending 2023-03-31 was $20.00K, a 50.00% decline year-over-year.
- EDESA BIOTECH, INC. related party transaction, expenses from transactions with related party for the quarter ending 2022-12-31 was $2.00K, a 99.00% decline year-over-year.
- EDESA BIOTECH, INC. related party transaction, expenses from transactions with related party for the quarter ending 2022-09-30 was -$529.00K.
- EDESA BIOTECH, INC. related party transaction, expenses from transactions with related party for the quarter ending 2022-06-30 was $200.00K, a 4.76% decline year-over-year.
- EDESA BIOTECH, INC. related party transaction, expenses from transactions with related party for fiscal 2022 was $81.00K, a 0.00% change from fiscal 2021.
- EDESA BIOTECH, INC. related party transaction, expenses from transactions with related party for fiscal 2021 was $81.00K, a 6.58% increase from fiscal 2020.
- EDESA BIOTECH, INC. related party transaction, expenses from transactions with related party for fiscal 2020 was $76.00K.
- EDESA BIOTECH, INC. related party transaction, expenses from transactions with related party for fiscal 2019 was $79.00K.
| Period end | Related Party Transaction, Expenses from Transactions with Related Party 3 month | Related Party Transaction, Expenses from Transactions with Related Party 3 month as first filed | Related Party Transaction, Expenses from Transactions with Related Party 6 month | Related Party Transaction, Expenses from Transactions with Related Party 6 month as first filed | Related Party Transaction, Expenses from Transactions with Related Party 9 month | Related Party Transaction, Expenses from Transactions with Related Party 9 month as first filed | Related Party Transaction, Expenses from Transactions with Related Party 12 month | Related Party Transaction, Expenses from Transactions with Related Party 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2023-03-31 | $20.00K 10-Q · filed 2023-05-11 | $20.00K 10-Q · filed 2023-05-11 | -$507.00K derived: sum of 3 quarters · filed 2023-05-11 | -$307.00K derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2022-12-31 | $2.00K 10-Q · filed 2023-02-10 | -$527.00K derived: sum of 2 quarters · filed 2023-02-10 | -$327.00K derived: sum of 3 quarters · filed 2023-02-10 | -$287.00K derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2022-09-30 | -$529.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-16 | -$329.00K derived: sum of 2 quarters · filed 2022-12-16 | -$289.00K derived: sum of 3 quarters · filed 2023-05-11 | $81.00K 10-K · filed 2022-12-16 | ||||
| 2022-06-30 | $200.00K 10-Q · filed 2022-08-12 | $240.00K derived: sum of 2 quarters · filed 2023-05-11 | $610.00K 10-Q · filed 2022-08-12 | -$89.00K derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2022-03-31 | $40.00K 10-Q · filed 2023-05-11 | $200.00K 10-Q · filed 2022-05-13 | $40.00K 10-Q · filed 2023-05-11 | $410.00K 10-Q · filed 2022-05-13 | -$289.00K derived: sum of 3 quarters · filed 2023-05-11 | -$79.00K derived: sum of 4 quarters · filed 2023-05-11 | ||
| 2021-12-31 | $200.00K 10-Q · filed 2023-02-10 | -$329.00K derived: sum of 2 quarters · filed 2023-02-10 | -$119.00K derived: sum of 3 quarters · filed 2023-02-10 | $81.00K derived: sum of 4 quarters · filed 2023-02-10 | ||||
| 2021-09-30 | -$529.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-28 | -$319.00K derived: sum of 2 quarters · filed 2022-08-12 | -$119.00K derived: sum of 3 quarters · filed 2022-08-12 | $81.00K 10-K · filed 2021-12-28 | ||||
| 2021-06-30 | $210.00K 10-Q · filed 2022-08-12 | $20.89K 10-Q · filed 2021-08-13 | $410.00K derived: sum of 2 quarters · filed 2022-08-12 | $610.00K 10-Q · filed 2022-08-12 | $60.83K 10-Q · filed 2021-08-13 | $628.92K derived: sum of 4 quarters · filed 2022-08-12 | ||
| 2021-03-31 | $200.00K 10-Q · filed 2022-05-13 | $20.25K 10-Q · filed 2021-05-14 | $400.00K 10-Q · filed 2022-05-13 | $39.94K 10-Q · filed 2021-05-14 | $418.92K derived: sum of 3 quarters · filed 2022-05-13 | $437.43K derived: sum of 4 quarters · filed 2022-05-13 | ||
| 2020-12-31 | $200.00K 10-Q · filed 2022-02-14 | $19.69K 10-Q · filed 2021-02-16 | $218.92K derived: sum of 2 quarters · filed 2022-02-14 | $237.43K derived: sum of 3 quarters · filed 2022-02-14 | $256.87K derived: sum of 4 quarters · filed 2022-02-14 | |||
| 2020-09-30 | $18.92K derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-28 | $37.43K derived: sum of 2 quarters · filed 2021-12-28 | $56.87K derived: sum of 3 quarters · filed 2021-12-28 | $76.00K 10-K · filed 2021-12-28 | $76.33K 10-K · filed 2020-12-07 | |||
| 2020-06-30 | $18.51K 10-Q · filed 2021-08-13 | $37.95K derived: sum of 2 quarters · filed 2021-08-13 | $57.08K 10-Q · filed 2021-08-13 | $77.30K derived: sum of 4 quarters · filed 2021-08-13 | ||||
| 2020-03-31 | $19.44K 10-Q · filed 2021-05-14 | $19.13K 10-Q · filed 2020-05-15 | $38.57K 10-Q · filed 2021-05-14 | $58.79K derived: sum of 3 quarters · filed 2021-05-14 | $77.58K derived: sum of 4 quarters · filed 2021-05-14 | |||
| 2019-12-31 | $19.44K 10-Q · filed 2021-02-16 | $39.35K derived: sum of 2 quarters · filed 2021-02-16 | $58.14K derived: sum of 3 quarters · filed 2021-02-16 | $79.00K 10-KT · filed 2019-12-12 | ||||
| 2019-09-30 | $19.91K derived: 10-K 9 month − 10-Q 6 month · filed 2020-12-07 | $38.70K derived: sum of 2 quarters · filed 2020-12-07 | $57.91K 10-K · filed 2020-12-07 | $58.00K 10-KT · filed 2019-12-12 | $77.81K derived: sum of 4 quarters · filed 2020-12-07 | |||
| 2019-06-30 | $18.79K 10-Q · filed 2020-08-12 | $19.00K 10-Q · filed 2019-08-14 | $38.00K 10-Q · filed 2019-08-14 | $57.90K 10-Q · filed 2020-08-12 | ||||
| 2019-03-31 | $19.30K 10-Q · filed 2020-05-15 | $39.11K 10-Q · filed 2020-05-15 | ||||||
| 2018-12-31 | $19.80K 10-Q · filed 2020-02-13 | |||||||
| 2018-06-30 | $20.00K 10-Q · filed 2019-08-14 | $40.00K 10-Q · filed 2019-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |